Holen Sie sich die Stockscreener-App
3.42
2.40%
0.08
Handel nachbörslich:
3.42
Alvotech Aktie (ALVO) Neueste Nachrichten
Alvotech founder Robert Wessman threatens to quit Britain over ‘anti-wealth’ tax regime - Business Matters
Alvotech Earnings Call Balances Setbacks and Momentum - The Globe and Mail
Alvotech plans June FDA resubmissions, sees biosimilar approvals by year-end - MSN
Does Alvotech’s (ALVO) FDA Inspection Outcome Reframe Confidence in Its Biosimilar Strategy for 2026? - simplywall.st
Alvotech stock (LU2557688560): 2026 outlook reaffirmed after earnings call - AD HOC NEWS
Earnings Preview: Alvotech to Report Financial Results on May 06 - 富途牛牛
Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag - MSN
Alvotech stock (LU2557688560): latest FDA approval progress and biosimilar pipeline in focus - AD HOC NEWS
Alvotech shares rise as FDA completes Reykjavik facility inspection - MSN
Alvotech faces FDA setback for its Simponi biosimilar AVT05 - MSN
Alvotech (NasdaqGM:ALVO) Valuation Check After FDA Form 483 And Reaffirmed Approval Timelines - simplywall.st
Nordic Stocks Decrease; Alvotech Takes Biggest Hit - 富途牛牛
EBITDA of Alvotech Swedish Depository Receipt Repr 1 Sh – TURQUOISE:ALVOS - TradingView
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End - MarketBeat
Transcript : Alvotech Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 03 - marketscreener.com
Alvotech stock (LU2557688560): Partner Fuji Pharma reports valuation drop - AD HOC NEWS
Alvotech (ALVO) Q1 2026 Earnings Transcript - AOL.com
Alvotech (ALVO) Is Down 7.4% After FDA Form 483 on Key Site Inspection Has The Bull Case Changed? - Sahm
ALVO Stock Price, Quote & Chart | ALVOTECH SA (NASDAQ:ALVO) - ChartMill
Alvotech’s Iceland Manufacturing Facility Passes FDA Surveillance Inspection - geneonline.com
Alvotech Assured After FDA Facility Feedback - Citeline News & Insights
Alvotech Receives US FDA Observations Following Iceland Plant Inspection - Moomoo
Alvotech Clears Key FDA Inspection at Reykjavik Plant, Paving Way for 2026 BLA Resubmissions - TipRanks
Alvotech (NASDAQ: ALVO) reports FDA Form 483 but maintains 2026 BLA approval outlook - Stock Titan
Alvotech advances after FDA wraps Iceland plant inspection - MSN
Alvotech announces cGMP surveillance inspection of Reykjavik facility - TipRanks
FDA completes inspection at Alvotech's Reykjavik facility; company on track for BLA resubmissions this quarter - Pluang
Alvotech announces completion of FDA surveillance inspection at Reykjavik facility - The Manila Times
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility - The Manila Times
FDA issues Form 483 at Iceland plant; Alvotech still targets 2026 drug approvals - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Alvotech reports completion of FDA inspection in Iceland - grafa.com
Alvotech stock (LU2557688560): Q1 2026 revenue dip and EBITDA rise on mix shift - AD HOC NEWS
Dr Reddy's Share Price: Hits ₹1,303.4 On June 5 After $29.5B Keytruda Biosimilar Deal With Alvotech (x8QfRltOd3) - Fathom Journal
Alvotech Earnings Call Balances Risk and Growth - The Globe and Mail
A Look At Alvotech (NasdaqGM:ALVO) Valuation After Weak Q1 2026 Results And Biosimilar Pipeline Updates - simplywall.st
ALVOW (Alvotech) warrants remain flat as quarterly earnings data not disclosed to markets.Current Ratio - newser.com
Nordic Shares Decline; Alvotech Posts Biggest Loss - Moomoo
Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift - Investing.com Canada
Alvotech Q1 2026 slides: revenue dips 20%, EBITDA rises on mix shift By Investing.com - Investing.com South Africa
Earnings call transcript: Alvotech misses Q1 2026 earnings, stock dips - Investing.com UK
Alvotech’s Earnings Swing And Counsel Exit Might Change The Case For Investing In ALVO - Yahoo Finance
Alvotech (NASDAQ:ALVO) Shares Gap DownTime to Sell? - MarketBeat
Alvotech Q1 2026 Financial Results - Sahm
Earnings call transcript: Alvotech misses Q1 2026 earnings, stock dips By Investing.com - Investing.com South Africa
Alvotech Q1 Earnings Call Highlights - MarketBeat
5.02%
5.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):